hotspot -WSS

hotspot

author：comprehensive 2025-08-28 08:39:47 - browse：671

People in business and medical wardrobe in a table discussion — coverage from STAT — Adobe

R1 RCM, a large publicly traded technology company that helps hospitals and physicians collect money from insurers and patients, may be going private.

Private equity firm New Mountain Capital has offered to purchase R1 for $13.75 per share, or roughly $5.8 billion in cash, according to new financial disclosures filed Monday. New Mountain Capital is R1’s second-largest investor, owning nearly one-third of the company’s shares.

In response to the offer, R1 asked New Mountain Capital to “engage in good faith discussions” with its largest investor — a partnership between Ascension, the large Catholic hospital system, and private equity firm TowerBrook Capital Partners. New Mountain Capital has since held several in-person meetings with Ascension and TowerBrook throughout February, but maintained its original offer for R1. No deal has been finalized yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： U.K. decision on ALS drug has neurologists, advocates up in arms

WSS

Florida Supreme Court upholds state's abortion ban

Scientific mystery highlights the blind spots in genomics databases

PBMs are inflating the cost of generic drugs. They must be reined in

Medicare Advantage 2025 payments will dip, Biden administration says

Covid silver lining: Unprecedented look at human immune system

Bird flu reported in person exposed to presumably infected cattle

leisure time

hotspot

knowledge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Meadows told special counsel he could not recall Trump ever declassifying Mar

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Pancreatic cancer is often deadly, but new discoveries are raising hope

Duchenne breakthrough therapy leaves behind pioneering families

Mass General Brigham physicians react to latest merger step

Virginia high school admissions case could be legal follow

Drug companies' payments and gifts affect physicians' prescribing

New air purifier tech could be key to improving indoor air quality

Hundreds died while taking an arthritis drug, but nobody alerted patients

knowledge

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Young boy dies in trial for Pfizer Duchenne gene therapy

FDA advisory panel to debate high blood pressure devices

Hospital at home shows how to bring innovation to health care

Intellia plays down concerns on accidental germline transmission

focus

entertainment

knowledge

leisure time